Condition: Crohn's Disease · Sponsor: Pfizer
This is a Phase 2/3 study that comprises 5 substudies designed to evaluate the efficacy, safety, and tolerability of oral etrasimod as therapy in adult participants with moderately to severely active Crohn's disease (CD) who are refractory or intolerant to at least 1 of the current therapies for CD (ie, corticosteroids, immunosuppressants, or biologics). The overall duration of this study is up to 282 weeks, inclusive of the Screening Period, Treatment Period of up to 274 weeks (Induction, Extension or Maintenance, and Long-term Extension Periods), and the 4-Week Follow-Up Period for safety assessment.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Center for Digestive Health (Endoscopy Location) | Dothan, Alabama, United States | — |
| Digestive Health Specialists | Dothan, Alabama, United States | — |
| Dothan Eyecare-Dr. Brent McKinley (OCT Location) | Dothan, Alabama, United States | — |
| Pulmonary Associates (PFT Location) | Dothan, Alabama, United States | — |
| Flowers Hospital (Imaging Location) | Dothan, Alabama, United States | — |
| Digestive Health Specialists (Satellite Clinic Location) | Mobile, Alabama, United States | — |
| Premier Medical Group East (Opthalmology & Optometry Facility) | Mobile, Alabama, United States | — |
| Pulmonary Associates (Chest X-Ray & PFT Facility) | Mobile, Alabama, United States | — |
| Surgicare of Mobile (Endoscopy & Biopsy Facility) | Mobile, Alabama, United States | — |
| Arizona Retina Institute/ Phoenix Retina Associates(OCT) | Peoria, Arizona, United States | — |
| SimonMed Imaging (Imaging) | Peoria, Arizona, United States | — |
| Sun City Endoscopy Center (Endoscopy) | Sun City, Arizona, United States | — |
+ 498 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.